MBX Biosciences, Inc.
Q4 2024 13F Holders
Symbol
MBX
CUSIP
55287L101
Type
Equity
Class
COM
Num filings
64
Total reported value, excl. options
$606 M
Compare 2024 Q4 to
2025 Q1
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type